Post-liver transplant hepatitis C virus recurrence: An unresolved thorny problem
Authors:
Open Access
- 1 January 2014
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 20 (32) , 11095-115
Abstract
Hepatitis C virus (HCV)-related cirrhosis represents the leading cause of liver transplantation in developed, Western and Eastern countries. Unfortunately, liver transplantation does not cure recipient HCV infection: reinfection universally occurs and disease progression is faster after liver transplant. In this review we focus on what happens throughout the peri-transplant phase and in the first 6-12 mo after transplantation: during this crucial period a completely new balance between HCV, liver graft, the recipient’s immune response and anti-rejection therapy is achieved that will deeply affect subsequent outcomes. Nearly all patients show an early graft reinfection, with HCV viremia reaching and exceeding pre-transplant levels; in this setting, histological assessment is essential to differentiate recurrent hepatitis C from acute or chronic rejection; however, differentiating the two patterns remains difficult. The host immune response (mainly cellular mediated) appears to be crucial both in the control of HCV infection and in the genesis of rejection, and it is also strongly influenced by immunosuppressive treatment. At present no clear immunosuppressive strategy could be strongly recommended in HCV-positive recipients to prevent HCV recurrence, even immunotherapy appears to be ineffective. Nonetheless it seems reasonable that episodes of rejection and over-immunosuppression are more likely to enhance the risk of HCV recurrence through immunological mechanisms. Both complete prevention of rejection and optimization of immunosuppression should represent the main goals towards reducing the rate of graft HCV reinfection. In conclusion, post-transplant HCV recurrence remains an unresolved, thorny problem because many factors remain obscure and need to be better determined.Keywords
This publication has 202 references indexed in Scilit:
- Distinct microRNA profiles are associated with the severity of hepatitis C virus recurrence and acute cellular rejection after liver transplantationLiver Transplantation, 2013
- A Human Monoclonal Antibody Targeting Scavenger Receptor Class B Type I Precludes Hepatitis C Virus Infection and Viral Spread In Vitro and In VivoHepatology, 2011
- ELISA-based detection of C4d after liver transplantation — A helpful tool for differential diagnosis between acute rejection and HCV-recurrence?Transplant Immunology, 2010
- Genetic variation in IL28B and spontaneous clearance of hepatitis C virusNature, 2009
- Influence of steroids on HCV recurrence after liver transplantation: A prospective studyJournal of Hepatology, 2007
- Outcomes in hepatitis C virus–infected recipients of living donor vs. deceased donor liver transplantationLiver Transplantation, 2006
- Impact of Donor Age on Survival and Fibrosis Progression in Patients With Hepatitis C Undergoing Liver Transplantation Using Hcv+ AllograftsLiver Transplantation, 2006
- Second hepatitis C replication compartment indicated by viral dynamics during liver transplantationJournal of Hepatology, 2005
- Decrease in hepatic CD56+ T cells and Vα24+ natural killer T cells in chronic hepatitis C viral infectionJournal of Hepatology, 2002
- Timing of reinfection and mechanisms of hepatocellular damage in transplanted hepatitis C virus-reinfected liverLiver Transplantation, 2002